Psych · Foundations — psychological and neuropsychological testing
Psychological and neuropsychological testing
Also known as Neuropsychological assessment psychiatry · Cognitive testing psychiatry · Psychometrics for psychiatrists · MATRICS MCCB · MoCA MMSE FAB · Performance validity testing
Exam-exhaustive fellowship reference on psychological and neuropsychological testing for psychiatrists — bedside screens (MMSE, MoCA, FAB, CAM), DSM-5 cognitive domains, formal NP referral, intelligence and personality testing principles, schizophrenia batteries (MATRICS MCCB, BACS, RBANS, HVLT-R), effort/validity (Slick/Sherman, TOMM), Green cognition–function evidence, practice effects and cultural pitfalls. FRANZCP-primary, globally tagged.
Practise this topic
On this page
Study tools
Your progress
Saved on this device.
Target exams
Red flags
- Treating MMSE or MoCA score as a dementia diagnosis without clinical syndrome and work-up
- Interpreting low scores without considering education, language, sensory limits, delirium, or effort
- Missing delirium — always consider CAM when acute fluctuation and inattention are present
- Ignoring performance validity when secondary gain, inconsistency, or near-chance recognition appears
- Equating IQ with decision-making capacity or overall competence
- Ordering exhaustive batteries without a focused clinical question
Meet the exam scene
A registrar presents a 72-year-old with a MoCA of 22 and writes: "mild dementia, start donepezil." The examiner leans in: "What does a MoCA of 22 actually prove, and what must you exclude first?"[2]
The honest answer: a MoCA of 22 is a finding — a screen that flags possible cognitive impairment and warrants further assessment. It is not a dementia diagnosis. Before any such label, you exclude delirium, you weigh education and language, and you build a syndrome from history, course, function, and aetiology.[2][5][7]
This topic is the cognitive-testing ladder — screens, batteries, intellectual and personality testing, and the effort-testing that protects every interpretation. The symptom scales (PHQ-9, PANSS) live in the rating-scales topic; here we own cognition and neuropsychology.[1][2][8]
References18ShowHide
- [1]Folstein MF, Folstein SE, McHugh PR "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician J Psychiatr Res, 1975.PMID 1202204
- [2]Nasreddine ZS, Phillips NA, Bédirian V, et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment J Am Geriatr Soc, 2005.PMID 15817019
- [3]Carson N, Leach L, Murphy KJ A re-examination of Montreal Cognitive Assessment (MoCA) cutoff scores Int J Geriatr Psychiatry, 2018.PMID 28731508
- [4]Dubois B, Slachevsky A, Litvan I, et al. The FAB: a Frontal Assessment Battery at bedside Neurology, 2000.PMID 11113214
- [5]Inouye SK, van Dyck CH, Alessi CA, et al. Clarifying confusion: the confusion assessment method. A new method for detection of delirium Ann Intern Med, 1990.PMID 2240918
- [6]Wei LA, Fearing MA, Sternberg EJ, et al. The Confusion Assessment Method: a systematic review of current usage J Am Geriatr Soc, 2008.PMID 18384586
- [7]Sachdev PS, Blacker D, Blazer DG, et al. Classifying neurocognitive disorders: the DSM-5 approach Nat Rev Neurol, 2014.PMID 25266297
- [8]Nuechterlein KH, Green MF, Kern RS, et al. The MATRICS Consensus Cognitive Battery, part 1: test selection, reliability, and validity Am J Psychiatry, 2008.PMID 18172019
- [9]Kern RS, Nuechterlein KH, Green MF, et al. The MATRICS Consensus Cognitive Battery, part 2: co-norming and standardization Am J Psychiatry, 2008.PMID 18172018
- [10]Green MF, Nuechterlein KH, Kern RS, et al. Functional co-primary measures for clinical trials in schizophrenia: results from the MATRICS Psychometric and Standardization Study Am J Psychiatry, 2008.PMID 18172017
- [11]Green MF What are the functional consequences of neurocognitive deficits in schizophrenia? Am J Psychiatry, 1996.PMID 8610818
- [12]Green MF, Kern RS, Braff DL, et al. Neurocognitive deficits and functional outcome in schizophrenia: are we measuring the "right stuff"? Schizophr Bull, 2000.PMID 10755673
- [13]Keefe RS, Goldberg TE, Harvey PD, et al. The Brief Assessment of Cognition in Schizophrenia: reliability, sensitivity, and comparison with a standard neurocognitive battery Schizophr Res, 2004.PMID 15099610
- [14]Randolph C, Tierney MC, Mohr E, et al. The Repeatable Battery for the Assessment of Neuropsychological Status (RBANS): preliminary clinical validity J Clin Exp Neuropsychol, 1998.PMID 9845158
- [15]Shapiro AM, Benedict RH, Schretlen D, et al. Construct and concurrent validity of the Hopkins Verbal Learning Test-revised Clin Neuropsychol, 1999.PMID 10726605
- [16]Slick DJ, Sherman EM, Iverson GL Diagnostic criteria for malingered neurocognitive dysfunction: proposed standards for clinical practice and research Clin Neuropsychol, 1999.PMID 10806468
- [17]Sherman EMS, Slick DJ, Iverson GL Multidimensional Malingering Criteria for Neuropsychological Assessment: A 20-Year Update of the Malingered Neuropsychological Dysfunction Criteria Arch Clin Neuropsychol, 2020.PMID 32377667
- [18]Teichner G, Wagner MT The Test of Memory Malingering (TOMM): normative data from cognitively intact, cognitively impaired, and elderly patients with dementia Arch Clin Neuropsychol, 2004.PMID 15033228